Co-Authors
This is a "connection" page, showing publications co-authored by MICHELLE DIANNE WILLIAMS and NANCY DUGAL PERRIER.
Connection Strength
2.237
-
Clinical significance of distinguishing between follicular lesion and follicular neoplasm in thyroid fine-needle aspiration biopsy. Ann Surg Oncol. 2009 Nov; 16(11):3146-53.
Score: 0.367
-
Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting. Hum Pathol. 2021 04; 110:73-82.
Score: 0.193
-
Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms. Endocr Pathol. 2019 Dec; 30(4):285-296.
Score: 0.184
-
Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center. Ann Surg Oncol. 2019 Oct; 26(11):3593-3599.
Score: 0.178
-
Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages. Surgery. 2018 11; 164(5):960-964.
Score: 0.168
-
The diagnostic accuracy of neck ultrasound, 4D-Computed tomographyand sestamibi imaging in parathyroid carcinoma. Eur J Radiol. 2017 Oct; 95:82-88.
Score: 0.157
-
Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma. J Am Coll Surg. 2017 Mar 15.
Score: 0.153
-
Oncologic progress for the treatment of parathyroid carcinoma is needed. J Surg Oncol. 2016 Nov; 114(6):708-713.
Score: 0.149
-
Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature. Int J Surg. 2016 Jul; 31:10-6.
Score: 0.144
-
Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer. Ann Surg Oncol. 2016 09; 23(9):2889-97.
Score: 0.144
-
Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas. Hum Pathol. 2011 Sep; 42(9):1213-20.
Score: 0.101
-
Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident. Surgery. 2019 01; 165(1):58-63.
Score: 0.043
-
Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions. Thyroid. 2018 10; 28(10):1301-1310.
Score: 0.043
-
Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core Pathways. J Endocr Soc. 2019 Mar 01; 3(3):544-559.
Score: 0.042
-
Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years. Pract Radiat Oncol. 2017 Nov - Dec; 7(6):e463-e470.
Score: 0.039
-
Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma. Thyroid. 2016 11; 26(11):1553-1562.
Score: 0.037
-
RET fusion as a novel driver of medullary thyroid carcinoma. J Clin Endocrinol Metab. 2015 Mar; 100(3):788-93.
Score: 0.033
-
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab. 2009 Feb; 94(2):386-91.
Score: 0.021
-
Recent advances in thyroid cancer. In brief. Curr Probl Surg. 2008 Mar; 45(3):149-51.
Score: 0.020
-
Recent advances in thyroid cancer. Curr Probl Surg. 2008 Mar; 45(3):156-250.
Score: 0.020